Clinical Trial Update: Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease [Phase 2]

View source ↗

Summary

A Phase 2 pilot, randomized, placebo-controlled study evaluated Lovaza in cardiovascular disease; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Heart Disease

Drugs mentioned

• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: HIV Infections, Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-04-09